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INTRODUCTION AND OBJECTIVES: Some reports suggested
that nephron sparing surgery (NSS) may protect against cardiovascular
events (CE) when compared with radical nephrectomy (RN) in patients
with small renal masses. However, the majority of those studies could
not adjust their results for potential selection bias secondary to clinical
baseline cardiovascular risk of the patients. In the current study, we
aimed to test the effect of treatment type (NSS vs. RN) on prevalence of
CE after accounting for clinical characteristics, comorbidities and indi-
vidual cardiovascular risk.
METHODS: A multi-institutional collaboration among four Eu-
ropean Tertiary Care Centers allowed collecting 1331 patients with a
clinical T1a-T1b N0 M0 renal mass and complete cardiovascular event
follow-up data. Patients underwent RN (n¼462, 34.7%) or NSS (n¼869,
65.3%) and showed normal estimated glomerular filtration rates (eGFR)
before surgery (defined as pre-operative eGFR60 ml/min/1.73 m2).
CE was defined as the onset of coronary artery disease, hypertensive
heart disease, heart failure, cardiac dysrhythmias or cerebrovascular
disease. Cox regression analyses predicting CE were performed. To
adjust for inherent baseline differences among patients, we relied on
multivariable analyses adjusting for age, clinical tumor size, gender,
presence of hypertension or diabetes, baseline Charlson comorbidity
index (CCI) and smoker status.
RESULTS: Mean patient age resulted 60.6 years (median 62).
Overall, 14.7% and 11% of the patients had uncontrolled hypertension
or diabetes, respectively. CCI resulted 0-1 in 70.8% of the patients. At a
mean follow up period of 71 months, 197 patients (14.8%) developed a
CE. When stratifying for treatment type, 10.5 vs. 22.9% patients
developed CE (p<0.001). At multivariable analyses, patients who un-
derwent PN showed significantly lower risk to harbour CE compared
with their RN-treated counterparts (odds ratio [OR]: 0.50; 95% confi-
dence interval, 0.26-0.96; p¼0.03). Presence of uncontrolled hyper-
tension (HR: 3.97, p¼0.01) and smoker status (OR: 1.96, p¼0.05)
resulted independent predictors of CE.
CONCLUSIONS: The risk of cardiovascular event after renal
surgery is not negligible. Patients treated with NSS have half of the risk
to develop CE relative to RN counterparts. Also after accounting for
clinical characteristics, comorbidities and cardiovascular risk at diag-
nosis, NSS independently decrease the risk of CE relative to RN.
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INTRODUCTION AND OBJECTIVES: ConnectTM is a novel
software accessory that adds remote proctoring ability to the da Vinci
robot. The interface allows proctors to provide real-time surgical advice
to training surgeons via a live bi-directional audio-visual feed with tel-
estration feature. The purpose of this study was to perform a feasibility
study of this interface with traditional in-room proctoring as a control.METHODS: Each training surgeon was randomized to in-room
or remote proctoring prior to each case. Inclusion criteria: 1) Selected
parts of robotic prostatectomy or partial nephrectomy & 2) Available
training, supervising and proctoring surgeons. Exclusion was per
attending surgeon discretion. Peri-operative objective data and post-
case subjective questionnaire data was collected. Trainee performance
was assessed with the validated GEARS (Global Evaluative Assess-
ment of Robotic Skills) assessment tool. Statistical comparison was
made by Krushkal-Wallace and paired t-tests.
RESULTS: In the 3-week pilot period, 20 of 32 potential cases
were enrolled (62.5%). Operating time for remotely proctored prosta-
tectomy (n¼9) was significantly shorter than in-room (n¼8) (p¼0.02),
while EBL was the same (p>0.05). Operating time and EBL was the
same for remote (n¼3) and in-room (n¼1) partial nephrectomies
(p>0.05). There was no difference detected between in-room and
remote proctor GEARS scores. Proctor and trainee feedback was
similar between in-room and remote experiences, except trainees felt
remote proctoring enhanced their "confidence as a surgeon” over in-
room proctoring (p¼0.006) and proctors felt the remote interface was
easier to use compared to the in-room mentoring interface (vision cart)
(p¼0.002). Both proctors and trainees positively rated all aspects of the
remote proctoring experience (mean scores 4-5 of 5). There was one
complication (bowel serosal injury) during in-room proctoring and one
instance in which the remote video feed froze requiring re-connection.
CONCLUSIONS: In this pilot study we showed that robotic
surgery trainees can be effectively and safely proctored in a remote
fashion. While definitive conclusions cannot be drawn due to limited
sample size, the ConnectTM interface was reviewed favorably compared
to in-room mentoring. We will continue to study ConnectTM and its po-
tential for inter-institutional application.
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